Related Experiment Video
Updated: Feb 8, 2026

06:49
Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
2.8K
Progressive Multifocal Leukoencephalopathy versus Brain Metastasis in a Patient with Locally-Advanced Non-Small Cell
Karah Odegaard1, David White2, Daniel G Petereit3
1University of South Dakota Sanford School of Medicine.
Summary
Progressive multifocal leukoencephalopathy (PML), a brain disease caused by the John Cunningham virus, can occur in immune-compromised patients. This case highlights PML mimicking brain metastasis after lung cancer treatment, emphasizing diagnostic importance.
Area of Science:
- Neuroscience
- Virology
- Oncology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a rare, demyelinating central nervous system disease.
- PML is caused by the John Cunningham virus (JCV), typically in individuals with compromised immunity, such as those with HIV/AIDS.
- Other immunosuppressive conditions can also predispose individuals to PML.
Observation:
- This report details a patient who developed PML after undergoing chemo-radiotherapy for non-small cell lung cancer.
- The patient's initial presentation of new brain lesions was more suggestive of brain metastasis.
Findings:
- The case underscores that PML can occur in the context of cancer treatment, even without HIV/AIDS.
- Accurate differentiation between PML and brain metastasis is crucial for appropriate patient management.
Implications:
- This case highlights the importance of considering PML in the differential diagnosis of new brain lesions in immunocompromised cancer patients.
- Early and accurate diagnosis of PML is essential to guide treatment and improve patient outcomes.
- Further research into the incidence and diagnosis of PML in non-HIV immunocompromised populations is warranted.
Related Concept Videos
mTOR Signaling and Cancer Progression
4.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.8K
Metastasis
6.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.6K
Lung Capacity
56.4K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K
Tumor Progression
7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Overview of Advanced Functional Groups
30.1K
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
30.1K
Extraction: Advanced Methods
1.2K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.2K

